Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 7, 2026
Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstructionMaximilian Moos, Tilman Emrich, Maximilian Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2017
Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction CancerYung-Jue Bang, Jae Yong Cho, Yeul Hong Kim, et al.
Anti-Cancer Drugs|January 25, 2003
Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancerMarkus Moehler, Tanja Hoffmann, Christine Zanke, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
BMC Cancer|July 2, 2014
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, et al.
BMC Cancer|December 21, 2006
Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinomaInes Gockel, Carl C Schimanski, Christian Heinrich, et al.
Annals of the New York Academy of Sciences|June 20, 2018
Molecular landscape of esophageal cancer: implications for early detection and personalized therapyFazlur Rahman Talukdar, Massimiliano di Pietro, Maria Secrier, et al.
Journal of Oncology|March 7, 2009
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced diseaseThomas C Wehler, Claudine Graf, Stefan Biesterfeld, et al.
World Journal of Gastroenterology|July 9, 2008
Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cellsHenning Schulze-Bergkamen, Roland Ehrenberg, Lothar Hickmann, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 7, 2026
Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstructionMaximilian Moos, Tilman Emrich, Maximilian Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2017
Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction CancerYung-Jue Bang, Jae Yong Cho, Yeul Hong Kim, et al.
Anti-Cancer Drugs|January 25, 2003
Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancerMarkus Moehler, Tanja Hoffmann, Christine Zanke, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
BMC Cancer|July 2, 2014
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, et al.
BMC Cancer|December 21, 2006
Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinomaInes Gockel, Carl C Schimanski, Christian Heinrich, et al.
Annals of the New York Academy of Sciences|June 20, 2018
Molecular landscape of esophageal cancer: implications for early detection and personalized therapyFazlur Rahman Talukdar, Massimiliano di Pietro, Maria Secrier, et al.
Journal of Oncology|March 7, 2009
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced diseaseThomas C Wehler, Claudine Graf, Stefan Biesterfeld, et al.
World Journal of Gastroenterology|July 9, 2008
Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cellsHenning Schulze-Bergkamen, Roland Ehrenberg, Lothar Hickmann, et al.
Pageof 22